Russia Approves Covid-19 Vaccine Sputnik-V Light For Use

Russia Approves Covid-19 Vaccine Sputnik-V Light For Use

Sputnik-V was the world’s first officially registered vaccine against the coronavirus. Developed by Russia.

After thorough research and study, Russia approved the use of Sputnik Light The first component of this vaccine (rAd 26) is approved by 60 countries from all around the world including India.

The study found that a single dose of the vaccine was 79.4% effective against the coronavirus. i.e., almost 80% of Scientists have concluded that this is higher than the effect of two doses of other vaccines.

A wide variety of corona vaccines are now available worldwide. And two doses of vaccine are mandatory to curb the virus.

Researchers say a single dose of the Sputnik-V light vaccine is enough. The reason why the Russian government has recently approved the Sputnik light single-dose vaccination.

Read More: Tips to boost your immunity

Russia Approves Covid-19 Vaccine Sputnik-V Light For Use

The vaccine has been found to work well against newer variants of the coronavirus. For 28 days after taking the single dose of Sputnik Light, 91.67 percent of the people’s body was found to have elevated antibodies. No serious side effects were reported in those who took the vaccine.

CEO Kirill Dmitriev stated out that, Sputnik-V Light will be exported to the international partners to help speed up the vaccination processes in the face of continuing pandemic and to fight the new coronavirus strains.”

The vaccine will be made available for less than $10.

Apart from Russia, Sputnik-V Light is being manufactured in at least 10 other countries with 20 manufacturers of the vaccine. Mr. Dmitriev noted that India, China, and South Korea are on the list of manufacturers, he said “the same output capacity” is carried out in all the places but did not explain how many doses.

Last month, India allowed Sputnik-V for emergency use after the first shipment of 1,5 lakh doses from Russia arrived in Hyderabad on May 1st.

Indian companies are in talks with DR. Reddy’s Laboratories, the marketing partner for Sputnik V in India to vaccinate their workforce and families.

Also Read: Serum Institute CEO Adar Poonawalla Says Vaccination Shortage Until July

Leave a Reply